Lupus Erythematosus, Systemic: all 1,222 studies

Page 8 of 13. Open to participants first (399), then studies with results posted, then the rest; newest registration first within each.

• Serum Levels of Angiotensin Converting Enzyme in Systemic Lupus Erythematous PatientsStatus unknownNCT05516511
• Type 1 Interferon Induced Changes to Exercise Adaptations in Systemic Lupus Erythematosus PatientsCompletedNCT05478018Not applicable
• A Study of CM313 Injection in Subjects With Systemic Lupus ErythematosusStatus unknownNCT05465707Phase 1/2
• 3TR (Taxonomy, Treatment, Targets and Remission) Systemic Lupus Erithematosus Study ProtocolActive, not recruitingNCT05458622Phase 3
• Monitoring of Inflammatory ConditionsCompletedNCT05458531
• Self-Acupressure on Pain, Fatigue and Sleep Quality in Systemic Lupus ErythematosusStatus unknownNCT05453422Not applicable
• At the Heart of the Matter - Speckle Tracking Echocardiography in Lupus Mothers and Their OffspringStatus unknownNCT05451277
• Probiotics in Systemic Lupus ErythematosusCompletedNCT05433857Phase 2
• Vitamin D and Curcumin Piperine Attenuates Disease Activity and Cytokine Levels in Systemic Lupus Erythematosus PatientsCompletedNCT05430087Phase 2
• Clinical Characteristics and Outcomes of SLE Patients Admitted to Critical Care UnitStatus unknownNCT05418855
• A Study of KK4277 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus and Cutaneous Lupus ErythematosusCompletedNCT05411016Phase 1
• Progressive Resisted Exercise Plus Aerobic Exercise on Osteoporotic Systemic Lupus ErythmatosusCompletedNCT05392790Not applicable
• Laser Puncture and Program of Lifestyle Modification in Lupus FemalesStatus unknownNCT05381545Not applicable
• Mediterranean vs. High-Fermented-Food Diet Adherence on Inflammation in LupusTerminatedNCT05379725Not applicable
• Prediction of Lupus Renal Flares StudyStatus unknownNCT05362812
• Precision Medicine in LN: A Multicenter Proof-of-concept Study for Histopathological Biomarkers Analysis in Renal BiopsyStatus unknownNCT05358652
• ELEVATE - (Empower Lupus Erythematosus Patients Via Allowing RemoTe Evaluation)CompletedNCT05347992
• Evaluation of Plasma Vitamin C Levels in a Population of Chronic Rheumatism in Immuno-RheumatologyCompletedNCT05345899Not applicable
• Effects of Telehealth Initiative on Lupus PatientsCompletedNCT05329831Not applicable
• A Phase Ia Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered CUG252 in Normal Healthy VolunteersCompletedNCT05328557Phase 1
• Effect of Cholecalciferol Supplementation on Disease Activity and Quality of Life of Systemic Lupus Erythematosus Patients .CompletedNCT05326841Phase 3
• Vagus Nerve Stimulation for Systemic Lupus ErythematousCompletedNCT05315739Not applicable
• NCF Gene & TNFSF4 in SLE PatientsStatus unknownNCT05314881Not applicable
• A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-1)TerminatedNCT05306574Phase 3
• Monıtorıng Glucocortıcoıd Treatment In Patıents Followed In Rheumatology ClınıcStatus unknownNCT05292456
• Motivating Individuals With Lupus to ExerciseCompletedNCT05287581Not applicable
• A Study to Assess the Safety, Tolerability, and Pharmacokinetics of E6742 in Systemic Lupus Erythematosus ParticipantsCompletedNCT05278663Phase 1/2
• Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- VTerminatedNCT05268289Phase 2
• Efficacy and Immunological Evaluation of Belimumab Plus Low Dose IL-2 in the Treatment of Systemic Lupus ErythematosusStatus unknownNCT05262686Phase 3
• Effects of an Intervention With EVOO and Physical Activity in Patients With Systemic Lupus ErythematosusStatus unknownNCT05261529Not applicable
• Effect of Vitamin D Supplement on Disease Activity in SLECompletedNCT05260255Not applicable
• Evaluation Of Serum MIF Level in SLE PatientsStatus unknownNCT05253638Not applicable
• Telitacicept Study in Chinese Subjects With Systemic Lupus ErythematosusCompletedNCT05247203Phase 1
• Lupus Education Alliance ProgramTerminatedNCT05243875Not applicable
• COvid-19 Vaccine Booster in Immunocompromised Rheumatic DiseasesStatus unknownNCT05236491Phase 2/3
• A Study of a Single Ascending Dose Study of DS-7011a in Healthy SubjectsCompletedNCT05203692Phase 1
• Multiple Ascending Dose Study of MHS552 in Adults Participants With Systemic Lupus Erythematosus (SLE)TerminatedNCT05203419Phase 1
• Clinical and Diagnostic Value of Ribosomal p2 Autoantibodies in Systemic Lupus ErythematosusStatus unknownNCT05179018
• The Effect of Deep Breathing and Transcutaneus Electrical Nerve Stimulation on Heart Rate VariabilityStatus unknownNCT05157334Not applicable
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered Mosunetuzumab to Participants With Systemic Lupus ErythematosusCompletedNCT05155345Phase 1
• Clonal Hematopoiesis of Indeterminate Potential and Accelerated Atherosclerosis in Systemic Lupus ErythematosusCompletedNCT05146414
• SAPHNELO Systemic Lupus Erythematosus Japan Post-Marketing Surveillance (PMS)Active, not recruitingNCT05141201
• A Study to Evaluate the Safety, Tolerability, and PK Profile of Single and Multiple Doses TJ202 in Patient With Systemic Lupus ErythematosusTerminatedNCT05140824Phase 1
• Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus NephritisActive, not recruitingNCT05138133Phase 3
• The Genital Tract Microflora in Women With Systemic Lupus Erythematosus (SLE) and Immunoglobulin A (IgA) Nephropathy.Status unknownNCT05132621
• Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus NephritisActive, not recruitingNCT05126277Phase 3
• Vaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19CompletedNCT05115370
• NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease ActivityStatus unknownNCT05106998
• Evaluation of Slit2 in Systemic Lupus Erythematosus and Systemic Sclerosis PatientsStatus unknownNCT05105217
• Exercise and Nutrition Recommendations for Patients Using Glucocorticoids (ENRG)Status unknownNCT05090189Not applicable
• Autologous Stem Cell Transplantation: International Lupus TrialWithdrawnNCT05063513Phase 2/3
• Reappraisal of the Therapies of Refractory Autoimmune Hemolytic Anemia in Systemic Lupus ErythematosusStatus unknownNCT05057481Phase 3
• IL17 in Systemic Lupus Erythematosus Patients: Association With Disease Activity and Organ DamageStatus unknownNCT05045417
• Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus ErythematosusActive, not recruitingNCT05039840Phase 2
• A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Systemic Lupus ErythematosusStatus unknownNCT05030779Early Phase 1
• AS-OCT Study of Cornea and Tear Film Parameters in Juvenile SLE PatientsStatus unknownNCT05015465
• Anifrolumab PK Study for Systemic Lupus Erythematosus (SLE)CompletedNCT05001698Phase 1
• The Effectiveness of Walking in Patients With Systemic Lupus ErythematosusStatus unknownNCT04983784Not applicable
• Cardiovascular Protective Role of Laser Acupuncture in Systemic LupusCompletedNCT04970199Not applicable
• Antiphospholipid Antibodies in Patients of Antiphospholipid Syndrome (APS) With Systemic Lupus Erythematosus (SLE).CompletedNCT04963881
• A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus ErythematosusActive, not recruitingNCT04963296Phase 3
• A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus ErythematosusActive, not recruitingNCT04961567Phase 3
• Belimumab In Early Systemic Lupus ErythematosusCompletedNCT04956484Phase 4
• PRediction Of Flares In Lupus With autoantibodiEs and ChemokinesStatus unknownNCT04951427
• Practice of Treat-to-target on Pediatric Systemic Lupus Erythematosus: a Two-center Retrospective StudyStatus unknownNCT04942314
• Individual Patient Expanded Access IND of Autologous HB-adMSCs for the Treatment of Systemic Lupus Erythematosus (SLE)No longer availableNCT04907175
• Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and InflammationCompletedNCT04902807
• A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)Active, not recruitingNCT04895696Phase 2
• A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus ErythematosusActive, not recruitingNCT04895241Phase 3
• A Study of Nipocalimab in Adult Participants With Active Systemic Lupus ErythematosusCompletedNCT04882878Phase 2
• Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus ErythematosusActive, not recruitingNCT04877691Phase 3
• AS-OCT Study of Cornea and Tear Film Parameters in SLE PatientsCompletedNCT04873739
• Stress, Inflammation and Immune Response Pilot Study- Aim 3CompletedNCT04857151Early Phase 1
• COVID-19 Vaccination in Rheumatic Disease PatientsTerminatedNCT04839315Early Phase 1
• An Open Label Study to Evaluate Daratumumab in Participants With Moderate to Severe Systemic Lupus ErythematosusStatus unknownNCT04810754Phase 2
• Expression of CXCR4 in Patients With Systemic Lupus ErythematosusStatus unknownNCT04799730
• Shotgun Mass Spectrometry-based Lipid Profiling in Chronic Inflammatory DiseasesCompletedNCT04786431
• Anifrolumab Early Access ProgramNo longer availableNCT04750057
• Study of Leukocyte Populations in Patients With Chronic InflammatoryStatus unknownNCT04749875
• Objective Measurement With TCM Pattern for AIDDESStatus unknownNCT04747288
• Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLEStatus unknownNCT04726553Early Phase 1
• Efficacy of Intense Pulsed Light in the Treatment of Facial Telangiectasia in Systemic Lupus ErythematosusStatus unknownNCT04717583Not applicable
• Efficacy of Fractional Er:YAG Laser in Lupus Erythematosus ScarsWithdrawnNCT04707924Not applicable
• A Study Evaluating the Effects of GLPG3970 Given as Oral Treatment for 12 Weeks in Adults With Systemic Lupus ErythematosusTerminatedNCT04700267Phase 1
• Epigenetics in Lupus NephritisStatus unknownNCT04648059
• Study of M5049 in CLE and SLE ParticipantsCompletedNCT04647708Phase 1
• Clinical Characteristic and MEFV Gene Mutations in Patient With Juvenile Onest Systemic Lupus ErythematosusStatus unknownNCT04645225
• Efficacy and Safety of Sirolimus in Active Systemic Lupus ErythematosusActive, not recruitingNCT04582136Phase 3
• Highly Sensitive Serum Cardiac Troponin T and Cardiovascular Events in Patients With Systemic Lupus ErythematosusCompletedNCT04580108
• Transcriptional and Immune Parameters of Response to BelimumabCompletedNCT04570306
• Evaluation of Serum Galectin-9 Level in Systemic Lupus Erythematosus Patients and it's Association With Disease Activity and Organ DamageStatus unknownNCT04558814Not applicable
• Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic DiseasesStatus unknownNCT04530461
• Neuromuscular Ultrasonography Utility for Detection of Peripheral Neuropathy in Systemic Lupus ErythematosusCompletedNCT04527172
• Long-term Follow-up for Evaluating the Safety of CS20AT04 in Subject with Lupus NephritisCompletedNCT04522505
• A Study on Protein Losing Enteropathy In Systemic Lupus ErythematosusStatus unknownNCT04517240
• Recombinant Zoster Vaccine in Stable SLE PatientsStatus unknownNCT04516408Not applicable
• Efficacy and Safety of Belimumab in SLE PatientsCompletedNCT04515719Phase 4
• A Study to Assess the Safety and Drug Levels of BMS-986256 in Participants With Active Cutaneous Lupus ErythematosusCompletedNCT04493541Phase 1
• Centrally Acting ACE Inhibition in SLEActive, not recruitingNCT04486118Phase 2
• Laser Therapy for Patients With Systemic Lupus ErythematosusCompletedNCT04453215Not applicable

← Lupus Erythematosus, Systemic overview